abstract |
The present invention relates to compounds of formula (0) In the above formulas, A 1 to A 8 , R 4 and R 5 each have the meanings as described herein. The compounds of formula (0) and pharmaceutical compositions thereof are useful for the treatment of diseases and disorders in which an undesirable or excessive activity of the NF-kB signal is observed. |